Home slider beeld 02
Lab website TS Essen.jpg

    In cancer, infection and inflammation, the immune system’s function is dysregulated, contributing to disease pathology. As part of this process, instead of fighting disease, immune cells may even suppress beneficial immune responses and increase pathology. Despite their pathophysiological importance, the identity and biology of the so called myeloid regulatory cells (MRCs) is poorly understood. 


    European Network of Investigators Triggering Exploratory Research on Myeloid Regulatory Cells


    Action Chair: Sven Brandau (DE)

    Vice-Chair: Annabel Valledor (ES)


    The COST Action Mye-EUNITER is proud to announce the first two publications of a Symposium-in-Writing in Cancer Immunology Immunotherapy which has been written by its members:

    Interactions among myeloid regulatory cells in cancer. Umansky V, Adema GJ, Baran 4, Brandau S, Van Ginderachter JA, Hu X, Jablonska J, Mojsilovic S, Papadaki HA, Pico de Coaña Y, Santegoets KCM, Santibanez JF, Serre K, Si Y, Sieminska I, Velegraki M, Fridlender ZG. Cancer Immunol Immunother. 2018 Jul 12. doi: 10.1007/s00262-018-2200-6.

    How to measure the immunosuppressive activity of MDSC: assays, problems and potential solutions. Bruger AM, Dorhoi A, Esendagli G, Barczyk-Kahlert K, van der Bruggen P, Lipoldova M, Perecko T, Santibanez J, Saraiva M, Van Ginderachter JA, Brandau S. Cancer Immunol Immunother. 2018 May 21. doi: 10.1007/s00262-018-2170-8

    © Springer-Verlag GmbH Germany, part of Springer Nature 2018

    1st review.jpg